KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-cash Items (2016 - 2019)

Historic Non-cash Items for Exact Sciences (EXAS) over the last 8 years, with Q3 2019 value amounting to $188.4 million.

  • Exact Sciences' Non-cash Items rose 4741.78% to $188.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $188.4 million, marking a year-over-year increase of 4741.78%. This contributed to the annual value of $120.8 million for FY2018, which is 2975.3% up from last year.
  • Latest data reveals that Exact Sciences reported Non-cash Items of $188.4 million as of Q3 2019, which was up 4741.78% from $224.8 million recorded in Q2 2019.
  • Exact Sciences' 5-year Non-cash Items high stood at $224.8 million for Q2 2019, and its period low was $38.2 million during Q2 2015.
  • Moreover, its 5-year median value for Non-cash Items was $54.1 million (2017), whereas its average is $94.0 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 97.32% in 2016, then surged by 15694.16% in 2018.
  • Quarter analysis of 5 years shows Exact Sciences' Non-cash Items stood at $41.1 million in 2015, then grew by 0.97% to $41.5 million in 2016, then surged by 124.34% to $93.1 million in 2017, then rose by 29.75% to $120.8 million in 2018, then soared by 55.96% to $188.4 million in 2019.
  • Its Non-cash Items was $188.4 million in Q3 2019, compared to $224.8 million in Q2 2019 and $209.2 million in Q1 2019.